Fibrobiologics Inc (FBLG)

Finanzdaten der Fibrobiologics Inc-Aktie (FBLG)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	20.42%4.03	5.07	2.59	5.04	4.49
Research and Development	43.85%1.66	2.95	0.80	2.79	2.04
Operating Income/Loss	20.42%-4.03	-5.07	-2.59	-5.04	-4.49
Nonoperating Income/Loss	223.53%-0.08	0.07	-0.65	-0.74	-
Income Tax Expense/Benefit	-	-	-	-	-
	17.66%-4.12	-5.00	-3.24	-5.78	-4.66
Attributable To Parent	17.66%-4.12	-5.00	-3.24	-5.78	-4.66
Basic Average Shares	66.25%6.27	3.77	5.17	43.07	38.64
Diluted Average Shares	66.25%6.27	3.77	5.17	43.07	38.64
Basic Earnings Per Share	50.38%-0.66	-1.33	-0.03	-0.13	-0.12
Diluted Earnings Per Share	50.38%-0.66	-1.33	-0.03	-0.13	-0.12